BANK VONTOBEL/CALL/CVS HEALTH/64/0.1/20.12.24 Share Price

Warrant

DE000VD5J5H4

Market Closed - Boerse Frankfurt Warrants 11:32:42 02/07/2024 pm IST
0.24 EUR -11.11% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/64/0.1/20.12.24
Current month-17.24%
1 month-20.00%
Date Price Change
02/24/02 0.24 -11.11%
01/24/01 0.27 -6.90%
28/24/28 0.29 +20.83%
27/24/27 0.24 -31.43%
26/24/26 0.35 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 02, 2024 at 11:32 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD5J5H
ISINDE000VD5J5H4
Date issued 03/05/2024
Strike 64 $
Maturity 20/12/2024 (171 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.42
Lowest since issue 0.142
Spread 0.01
Spread %4.00%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.52 USD
Average target price
69.1 USD
Spread / Average Target
+20.12%
Consensus